Boston Scientific executives said that the company's earnings per share and revenue growth rate are expected to increase significantly in 2028.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.